Mulroy Michael H. 4
4 · AgeX Therapeutics, Inc. · Filed Mar 13, 2019
Insider Transaction Report
Form 4
Mulroy Michael H.
Director
Transactions
- Award
Option to Purchase Common Stock
2019-03-11+65,000→ 65,000 totalExercise: $4.28Exp: 2029-03-10→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]Options will become exercisable in four equal quarterly installments from the date of grant on March 11, 2019 provided that the grantee remains a director on the last day of the applicable calendar quarter.